Aurora Cannabis Inc
NASDAQ:ACB
Aurora Cannabis Inc
Capital Expenditures
Aurora Cannabis Inc
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aurora Cannabis Inc
TSX:ACB
|
Capital Expenditures
-CA$14.8m
|
CAGR 3-Years
53%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
Bausch Health Companies Inc
TSX:BHC
|
Capital Expenditures
-$272m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
Canopy Growth Corp
TSX:WEED
|
Capital Expenditures
-CA$7m
|
CAGR 3-Years
69%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
Cronos Group Inc
TSX:CRON
|
Capital Expenditures
-$2.5m
|
CAGR 3-Years
59%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Capital Expenditures
-$89.8m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
T
|
Terrascend Corp
CNSX:TER
|
Capital Expenditures
-$41.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aurora Cannabis Inc's Capital Expenditures?
Capital Expenditures
-14.8m
CAD
Based on the financial report for Dec 31, 2023, Aurora Cannabis Inc's Capital Expenditures amounts to -14.8m CAD.
What is Aurora Cannabis Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
42%
Over the last year, the Capital Expenditures growth was 38%. The average annual Capital Expenditures growth rates for Aurora Cannabis Inc have been 53% over the past three years , 42% over the past five years .